Study to Assess Safety and Efficacy of Treating Symptomatic, Ischemic, Chronic Congestive Heart Failure Patients with an LVEF of ≤40% with Fresh, Uncultured, Autologous, Adipose-derived Regenerative Cells Isolated from Lipoaspirate.
Clinical trial NCT06705023 · RECRUITING
Trial details
- NCT number
- NCT06705023
- Sponsor
- Ralf Rothoerl
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-18
- Primary completion
- 2025-10-31
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.